Tying Drug Prices To What Other Countries Pay: A Pioneering Way To Curb Costs Or The Death Knell For Innovation?

The plan to tie prices of drugs to what other countries pay is a lightning rod in the debate over high drug costs. “The countries in the reference pricing have longer life expectancy, better health outcomes, and spend about half of what we on health care,” says David Mitchell, the president of Patients for Affordable Drugs. On the other side, is PhRMA's Jenny Bryant, who calls the proposal "draconian" and believes it will stifle innovation. Meanwhile, Republicans are siding with the latter position.

from Kaiser Health News https://ift.tt/2rcRGAT